EP 2670408 A1 20131211 - (5S,8S)-3-(4'-CHLOR-3'-FLUOR-4-METHLYBIPHENYL-3-YL)-4-HYDROXY-8-METHOXY-1-AZASPIRO[4.5]DEC-3-EN-2-ONE (COMPOUND A) FOR TREATMENT
Title (en)
(5S,8S)-3-(4'-CHLOR-3'-FLUOR-4-METHLYBIPHENYL-3-YL)-4-HYDROXY-8-METHOXY-1-AZASPIRO[4.5]DEC-3-EN-2-ONE (COMPOUND A) FOR TREATMENT
Title (de)
(5S,8S)-3-(4'-CHLOR-3'-FLUOR-4-METHYLBIPHENYL-3-YL)-4-HYDROXY-8-METHOXY-1-AZASPIRO[4.5]DEC-3-EN-2-ON (VERBINDUNG A) ZUR THERAPIE
Title (fr)
UTILISATION DE (5S,8S)-3-(4'-CHLORO-3'-FLUORO-4-MÉTHYLBIPHÉNYL-3-YL)-4-HYDROXY- 8-MÉTHOXY-1-AZASPIRO[4.5]DÉCANE-3-EN-2-ONE (COMPOSÉ A) À DES FINS THÉRAPEUTIQUES
Publication
Application
Priority
- DE 102011011040 A 20110208
- KW 1411 A 20110206
- EP 2012051895 W 20120203
Abstract (en)
[origin: WO2012104428A1] The invention relates to (5s,8s)-3-(4'-chlor-3'-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one for therapeutic purposes, pharmaceutical agents, and the use thereof in treatment, in particular for the prophylaxis and treatment of tumor diseases.
IPC 8 full level
A61K 31/4015 (2006.01); A61K 45/06 (2006.01)
CPC (source: EP KR US)
A61K 31/4015 (2013.01 - EP KR US); A61K 31/404 (2013.01 - KR); A61K 45/06 (2013.01 - EP KR US); A61P 35/00 (2017.12 - EP); C07D 209/54 (2013.01 - EP US)
Citation (search report)
See references of WO 2012104428A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012104428 A1 20120809; AP 2013007057 A0 20130831; AR 085146 A1 20130911; AU 2012213344 A1 20130822; BR 112013020015 A2 20170321; CA 2826515 A1 20120809; CL 2013002247 A1 20140103; CN 103533932 A 20140122; EA 201391084 A1 20140228; EP 2670408 A1 20131211; IL 227804 A0 20130930; JP 2014504624 A 20140224; KR 20140053844 A 20140508; MA 34887 B1 20140201; MX 2013009065 A 20131001; TN 2013000336 A1 20150120; TW 201240659 A 20121016; US 2014031407 A1 20140130; US 9212140 B2 20151215
DOCDB simple family (application)
EP 2012051895 W 20120203; AP 2013007057 A 20120203; AR P120100376 A 20120206; AU 2012213344 A 20120203; BR 112013020015 A 20120203; CA 2826515 A 20120203; CL 2013002247 A 20130806; CN 201280016212 A 20120203; EA 201391084 A 20120203; EP 12704386 A 20120203; IL 22780413 A 20130805; JP 2013552225 A 20120203; KR 20137023276 A 20120203; MA 36152 A 20130802; MX 2013009065 A 20120203; TN 2013000336 A 20130805; TW 101103805 A 20120206; US 201213983165 A 20120203